2014
DOI: 10.1016/j.canlet.2013.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Cancer stem cells: A contentious hypothesis now moving forward

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
165
0
2

Year Published

2015
2015
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 216 publications
(170 citation statements)
references
References 89 publications
3
165
0
2
Order By: Relevance
“…The CSC model is also involved in tumour heterogeneity 64,65 . Specifically, genetically distinct subclones together with developmental pathways and epigenetic modifications can contribute to functional heterogeneity and chemoresistance 65 .…”
Section: Cancer Stem Cellsmentioning
confidence: 99%
“…The CSC model is also involved in tumour heterogeneity 64,65 . Specifically, genetically distinct subclones together with developmental pathways and epigenetic modifications can contribute to functional heterogeneity and chemoresistance 65 .…”
Section: Cancer Stem Cellsmentioning
confidence: 99%
“…These cells have also been termed "cancer stem cells," or "cancer-initiating cells," and can grow into tumorigenic, multicellular spheroids under low attachment conditions. Although the hierarchical model of TIC development may be dynamic, TICs do share many of the same features as normal stem cells including quiescence, resistance to chemotherapy, long-term self-renewal and ability to differentiate into various cell lineages 7,8 .…”
Section: Introductionmentioning
confidence: 99%
“…22 However, in spite of these and other objections, the continued accumulation of experimental data provides increasing support for the CSC hypothesis. 17,[23][24][25][26][27][28] EPITHELIAL TO MESENCHYMAL TRANSITION During epithelial to mesenchymal transition (EMT), cells lose cellular adhesion and polarity and acquire an invasive phenotype. 29,30 EMT is associated with loss of E-cadherin and increased expression of other biomarkers including Snail, Slug, ZEB1, ZEB2 and N-cadherin (Figures 1 and 2; Table 2).…”
mentioning
confidence: 99%